Ameritas Investment Partners’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-4,066
| Closed | -$75.4K | – | 3128 |
|
|
2023
Q3 | $75.4K | Buy |
4,066
+1,776
| +78% | +$20.1K | ﹤0.01% | 1848 |
|
|
2023
Q2 | $25.3K | Hold |
2,290
| – | – | ﹤0.01% | 2434 |
|
|
2023
Q1 | $30.8K | Hold |
2,290
| – | – | ﹤0.01% | 2251 |
|
|
2022
Q4 | $36.4K | Hold |
2,290
| – | – | ﹤0.01% | 2259 |
|
|
2022
Q3 | $31K | Hold |
2,290
| – | – | ﹤0.01% | 2294 |
|
|
2022
Q2 | $31K | Hold |
2,290
| – | – | ﹤0.01% | 2303 |
|
|
2022
Q1 | $37K | Hold |
2,290
| – | – | ﹤0.01% | 2242 |
|
|
2021
Q4 | $37K | Hold |
2,290
| – | – | ﹤0.01% | 2329 |
|
|
2021
Q3 | $34K | Hold |
2,290
| – | – | ﹤0.01% | 2403 |
|
|
2021
Q2 | $46K | Hold |
2,290
| – | – | ﹤0.01% | 2251 |
|
|
2021
Q1 | $53K | Hold |
2,290
| – | – | ﹤0.01% | 2057 |
|
|
2020
Q4 | $57K | Hold |
2,290
| – | – | ﹤0.01% | 1905 |
|
|
2020
Q3 | $95K | Hold |
2,290
| – | – | ﹤0.01% | 1461 |
|
|
2020
Q2 | $110K | Buy |
2,290
+97
| +4% | +$7.49K | 0.01% | 1361 |
|
|
2020
Q1 | $138K | Hold |
2,193
| – | – | 0.01% | 1097 |
|
|
2019
Q4 | $272K | Buy |
2,193
+81
| +4% | +$7.25K | 0.01% | 932 |
|
|
2019
Q3 | $140K | Hold |
2,112
| – | – | 0.01% | 1264 |
|
|
2019
Q2 | $168K | Buy |
2,112
+304
| +17% | +$27.2K | 0.01% | 1164 |
|
|
2019
Q1 | $202K | Hold |
1,808
| – | – | 0.01% | 1048 |
|
|
2018
Q4 | $182K | Hold |
1,808
| – | – | 0.01% | 1017 |
|
|
2018
Q3 | $228K | Hold |
1,808
| – | – | 0.01% | 1013 |
|
|
2018
Q2 | $152K | Buy |
+1,808
| New | +$132K | 0.01% | 1249 |
|
|
2014
Q2 | – | Sell |
-616
| Closed | -$203K | – | 1116 |
|
|
2014
Q1 | $203K | Buy |
+616
| New | +$208K | 0.02% | 968 |
|
Ameritas Investment Partners's ICPT Position: Q4 2023 in Review
Ameritas Investment Partners sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2023, closing a stake of 4,066 shares — an estimated $75.4K sold.
Ameritas Investment Partners first reported a position in ICPT in Q1 2014 and held it in 23 quarters. The position peaked at $272K in Q4 2019. 0 funds tracked by Wall St. Rank hold ICPT as of Q4 2023.
- Ameritas Investment Partners reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2023 after selling out during the quarter.
- Ameritas Investment Partners sold 4,066 Intercept Pharmaceuticals, Inc. shares in Q4 2023, an estimated $75.4K.
- Ameritas Investment Partners first reported a position in Intercept Pharmaceuticals, Inc. in Q1 2014 and held it in 23 quarters.
- Ameritas Investment Partners's Intercept Pharmaceuticals, Inc. position peaked at $272K in Q4 2019.
- 0 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2023.
Based on Ameritas Investment Partners's 13F filing for Q4 2023, filed 14 Feb 2024.